Skip to main content

Table 2 Quantitative variables of the subjects as a function of the diagnosis of premorbid metabolic syndrome based on the WHO proposal

From: Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study

 

Total n = 621

Pre-MetS n = 136

Non Pre-MetS n = 485

p

Age (years)

48.5 (SD = 12.4)

54.5 (SD = 9.2)

46.8 (SD = 12.7)

<0.001

Waist C (cm)

92.0 (SD = 13.6)

103.3 (SD = 11.8)

88.8 (SD = 12.3)

<0.001

BMI (kg/m2)

26.3 (SD = 4.5)

29.8 (SD = 4.6)

25.3 (SD = 3.9)

<0.001

Fasting glucose(mg/dl)

93.7 (SD = 14.3)

105.5 (SD = 17.9)

90.3 (SD = 10.9)

<0.001

Total cholesterol (mg/dl)

205.3 (SD = 39.9)

219.5 (SD = 41.1)

201.4 (SD = 38.7)

<0.001

HDL-cholesterol (mg/dl)

58.8 (SD = 14.7)

49.2 (SD = 13.4)

61.5 (SD = 14.0)

<0.001

Triglyceride (mg/dl)

122.7 (SD = 83.4)

189.3 (SD = 132.7)

103.8 (SD = 48.8)

<0.001

SBP (mm Hg)

126.8 (SD = 16.2)

138.3 (SD = 15.5)

123.6 (SD = 14.9)

<0.001

DBP (mm Hg)

77.0 (SD = 10.4)

82.7 (SD = 10.7)

75.4 (SD = 9.6)

<0.001

CVR (Score)

1.5 (SD = 1.9)

2.5 (SD = 2.3)

1.2 (SD = 1.5)

<0.001

CVR (Regicor)

3.3 (SD = 2.3)

4.8 (SD = 2.6)

2.8 (SD = 1.9)

<0.001

  1. p ≤ 0.05 is considered to be statistically significant.
  2. Data are expressed as means (Standard Deviation).
  3. Pre-MetS premorbid metabolic syndrome; BMI body mass index; SBP systolic blood pressure; DBP diastolic blood pressure; CVR cardiovascular risk.